ID

20766

Descripción

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01517555

Link

https://clinicaltrials.gov/show/NCT01517555

Palabras clave

Versiones (2)
  1. 15/3/17 15/3/17 -
  2. 15/3/17 15/3/17 -
Subido en

15 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01517555

Inglés

Eligibility Diabetes NCT01517555

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01517555
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
diet-treated subjects with type 2 diabetes with hba1c 7.5-9.5 %
Descripción

Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Glycosylated hemoglobin A Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012159
UMLS CUI [1,2]
C0011860
UMLS CUI [2,1]
C0019018
UMLS CUI [2,2]
C0439165
subjects with type 2 diabetes in oral anti-diabetic drug (oad) monotherapy treated with metformin or alpha-glucosidase inhibitors with hba1c 7.0-9.5%
Descripción

Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus | Metformin | alpha-Glucosidase Inhibitors | Glycosylated hemoglobin A Percent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0011860
UMLS CUI [2]
C0025598
UMLS CUI [3]
C1299007
UMLS CUI [4,1]
C0019018
UMLS CUI [4,2]
C0439165
body mass index (bmi) 18.5-40 kg/m^2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
subjects should have a stable body weight for at least 3 months prior to screening (as judged by the investigator)
Descripción

Stable body weight

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0517386
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Descripción

Liver Dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Descripción

Renal Insufficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
clinically significant active cardiovascular disease including history of myocardial infarction within the last 6 months and/or heart failure
Descripción

Cardiovascular Diseases | Myocardial Infarction | Heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0018801
any clinically significant abnormal ecg (electrocardiogram)
Descripción

Electrocardiogram abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0522055
uncontrolled treated/untreated hypertension
Descripción

Uncontrolled hypertension Treated | Uncontrolled hypertension untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332155
recurrent severe hypoglycaemia as judged by the investigator
Descripción

Recurrent severe hypoglycemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342316
active hepatitis b and/or active hepatitis c
Descripción

Hepatitis B | Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
positive human immunodeficiency virus (hiv) antibodies
Descripción

HIV antibody positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920548
known or suspected allergy to trial product(s) or related products
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0750491
UMLS CUI [3,3]
C0013230
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0439849
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01517555

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01517555
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Glycosylated hemoglobin A Percentage
Item
diet-treated subjects with type 2 diabetes with hba1c 7.5-9.5 %
boolean
C0012159 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C0019018 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus | Metformin | alpha-Glucosidase Inhibitors | Glycosylated hemoglobin A Percent
Item
subjects with type 2 diabetes in oral anti-diabetic drug (oad) monotherapy treated with metformin or alpha-glucosidase inhibitors with hba1c 7.0-9.5%
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0011860 (UMLS CUI [1,3])
C0025598 (UMLS CUI [2])
C1299007 (UMLS CUI [3])
C0019018 (UMLS CUI [4,1])
C0439165 (UMLS CUI [4,2])
Body mass index
Item
body mass index (bmi) 18.5-40 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Stable body weight
Item
subjects should have a stable body weight for at least 3 months prior to screening (as judged by the investigator)
boolean
C0517386 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Liver Dysfunction
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
Cardiovascular Diseases | Myocardial Infarction | Heart failure
Item
clinically significant active cardiovascular disease including history of myocardial infarction within the last 6 months and/or heart failure
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
Electrocardiogram abnormal
Item
any clinically significant abnormal ecg (electrocardiogram)
boolean
C0522055 (UMLS CUI [1])
Uncontrolled hypertension Treated | Uncontrolled hypertension untreated
Item
uncontrolled treated/untreated hypertension
boolean
C1868885 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Recurrent severe hypoglycemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
active hepatitis b and/or active hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
HIV antibody positive
Item
positive human immunodeficiency virus (hiv) antibodies
boolean
C0920548 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related
Item
known or suspected allergy to trial product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0439849 (UMLS CUI [4,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial